FDA Adds Child Exposure Warnings to Solvay Pharmaceuticals, Inc., Auxilium Pharmaceuticals Testosterone Gel

Reuters -- The U.S. Food and Drug Administration said on Thursday it will require strong warnings to be added to two testosterone replacement gel products after numerous reports of troubling side effects in children who were exposed to the medicines.